Xu Jiandong — SEC Form 4 filings

SEC reporting owner CIK 1920399. 4 Form 4 filings on record with FilingPulse; latest filed 2026-08-25.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-09-16 to 2026-08-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Estrella Immunopharma, Inc. (ESLA)Chief Financial Officer33 legs · 2,100 sh · $2,5944
Denali Capital Acquisition Corp. (DECA)10% owner11

Form 4 filings — Xu Jiandong

FiledFormIssuerReported transactionsSource
2026-08-254Estrella Immunopharma, Inc. (ESLA)Option exercise (M): 100,000 @ $0.81 · Option exercise (M): 100,000 (derivative)EDGAR
2026-04-294Estrella Immunopharma, Inc. (ESLA)Purchase (P): 100 @ $1.04 · Purchase (P): 1,000 @ $1.16 · Purchase (P): 1,000 @ $1.33EDGAR
2025-02-144Estrella Immunopharma, Inc. (ESLA)Grant/award (A): 490,796 (derivative) · Grant/award (A): 509,204 (derivative)EDGAR
2024-09-164Denali Capital Acquisition Corp. (DECA)Sale (S): 500,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1920399 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →